A detailed history of Amundi transactions in Insmed Inc stock. As of the latest transaction made, Amundi holds 54 shares of INSM stock, worth $3,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 42 28.57%
Holding current value
$3,870
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$65.25 - $83.83 $783 - $1,005
12 Added 28.57%
54 $4,000
Q4 2024

Feb 07, 2025

BUY
$66.29 - $76.63 $2,784 - $3,218
42 New
42 $2,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $54,835 - $70,847
-2,118 Reduced 30.1%
4,918 $116,000
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $170,060 - $253,366
7,036 New
7,036 $200,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.71B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.